Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
NeoGenomics is a leading US-based oncology diagnostics company. It offers comprehensive molecular, genomic, and pathology cancer testing to physicians, hospitals, and pharmaceutical companies worldwide, advancing precision medicine. The company's innovative diagnostic solutions support targeted cancer treatment and pharmaceutical research.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
NeoGenomics is scheduled to report its next quarterly earnings on 11/10/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
NeoGenomics last reported quarterly earnings on 7/28/2026 (Q2 2026). Earnings per share (EPS) came in at 0.05 USD.
Across its last 3 earnings reports, NeoGenomics stock moved by ±1.2% on average the following day. The largest reaction was -2.4% on 10/28/2025; 1 of 3 reactions were positive.
NeoGenomics has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.